|
AU7233691A
|
|
Dna sequences from specific human genomic loci useful for identification of individuals
|
|
AU5358990A
|
|
Multiplex dna diagnostic test
|
|
EP0382332A2
|
|
Improved supersecreting mutants of saccharomyces cerevisiae
|
|
AU3410289A
|
|
Plasminogen activators with increased fibrin selectivity
|
|
US5139936A
|
|
Use of the GAL1 yeast promoter
|
|
US5051264A
|
|
Potentiation of the thrombolytic effect of prourokinase type plasminogen activators by streptokinase
|
|
EP0316068A1
|
|
Modified low molecular weight plasminogen activator and method of preparation
|
|
AU1893988A
|
|
Nonglycosylated plasminogen activator and method of preparation
|
|
US4999194A
|
|
Two-chain urokinase plasminogen activators for treatment of thrombotic disease
|
|
US5108923A
|
|
Bioadhesives for cell and tissue adhesion
|
|
JPS62265984A
|
|
Amino acid modified prourokinase and its production
|
|
EP0236040A2
|
|
Amino acid modified prourokinase and method of preparation
|
|
EP0226288A2
|
|
Means and method of testing for cystic fibrosis based on genetic linkage
|
|
US4828821A
|
|
Method of inhibiting calculus formulation and improving dental hygiene
|
|
EP0221633A1
|
|
Genotyping by restriction fragment length polymorphisms
|
|
JPS6265694A
|
|
Super-secretory yeast variant and production of protein therefrom
|
|
EP0201208A1
|
|
Supersecreting mutants of saccharomyces cerevisiae
|
|
WO8401153A1
|
|
Production of interferon in yeast by use of invertase promoter
|
|
AU2037083A
|
|
Production of interferon in yeast by use of invertase promoter
|
|
IL69664D0
|
|
Medium supplement and method for growing cells in vitro
|
